These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1128651)

  • 1. Single dose metyrapone test: 11 beta-hydroxylase inhibition by metyrapone and reduced metyrapone assayed by radioimmunoassay.
    Meikle AW; West SC; Weed JA; Tyler FH
    J Clin Endocrinol Metab; 1975 Feb; 40(2):290-5. PubMed ID: 1128651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved single-dose metyrapone test.
    Dickstein G; Barzilai D
    Isr J Med Sci; 1980 May; 16(5):365-9. PubMed ID: 6249771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short time kinetics of deoxycorticosterone, deoxycortisol, corticosterone and cortisol during single dose metyrapone test.
    Schöneshöfer M; L'age M; Oelkers W
    Acta Endocrinol (Copenh); 1977 May; 85(1):109-17. PubMed ID: 577070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased response of plasma cortisol to intravenous metyrapone in ocular hypertension and primary open-angle glaucoma.
    Schwartz B; Wysocki A; Qi Y
    J Glaucoma; 2005 Dec; 14(6):474-81. PubMed ID: 16276280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-dose metyrapone test at 06.00 h: an accurate method for assessment of pituitary-adrenal reserve.
    Dickstein G; Lahav M; Orr ZS
    Acta Endocrinol (Copenh); 1986 May; 112(1):28-34. PubMed ID: 3716755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased adrenal androgen secretion with inhibition of 11beta-hydroxylase in HIV-infected women.
    Koutkia P; Berry J; Eaton K; Breu J; Grinspoon S
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E808-13. PubMed ID: 16303845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of 11beta-hydroxylase activity with plasma corticosterone, deoxycorticosterone, cortisol, and deoxycortisol: role of ACTH and angiotensin.
    Ganguly A; Meikle AW; Tyler FH; West CD
    J Clin Endocrinol Metab; 1977 Mar; 44(3):560-8. PubMed ID: 190262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothalamic-pituitary-adrenal axis function in very low birth weight infants treated with dexamethasone.
    Alkalay AL; Pomerance JJ; Puri AR; Lin BJ; Vinstein AL; Neufeld ND; Klein AH
    Pediatrics; 1990 Aug; 86(2):204-10. PubMed ID: 2371095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of adrenal function by the anti-serotonin agent cyproheptadine.
    Plonk J; Feldman J
    J Clin Endocrinol Metab; 1976 Feb; 42(2):291-5. PubMed ID: 177441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined stimulation of adrenocorticotropin and compound-S by single dose metyrapone test as an outpatient procedure to assess hypothalamic-pituitary-adrenal function.
    Berneis K; Staub JJ; Gessler A; Meier C; Girard J; Müller B
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5470-5. PubMed ID: 12466339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of immunoreactive beta-endorphin in normal human plasma: a concomitant release of beta-endorphin with adrenocorticotropin after metyrapone administration.
    Nakao K; Nakai Y; Oki S; Horii K; Imura H
    J Clin Invest; 1978 Dec; 62(6):1395-8. PubMed ID: 219030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metyrapone test and plasma hormone estimations (author's transl)].
    Ducassou D; Rashedi M; Brendel A; Gasparoux S
    Pathol Biol (Paris); 1977 Dec; 25(10):729-33. PubMed ID: 206869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothalamic-pituitary-adrenal axis function in premature neonates after extensive prenatal treatment with betamethasone: a case history.
    Kairalla AB
    Am J Perinatol; 1992; 9(5-6):428-30. PubMed ID: 1418149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of altered thyroid hormone levels on hypothalamic-pituitary-adrenal function.
    Kamilaris TC; DeBold CR; Pavlou SN; Island DP; Hoursanidis A; Orth DN
    J Clin Endocrinol Metab; 1987 Nov; 65(5):994-9. PubMed ID: 3499449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of adrenal 18-hydroxylase inhibition by metyrapone in man.
    Schöneshöfer M; Schefzig B; Oelkers W
    Horm Metab Res; 1979 Apr; 11(4):306-8. PubMed ID: 222662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma metyrapone, adrenocorticotropic hormone, cortisol, and deoxycortisol levels. Sequential changes during oral and intravenous metyrapone administration.
    Jubiz W; Matsukura S; Meikle AW; Harada G; West CD; Tyler FH
    Arch Intern Med; 1970 Mar; 125(3):468-71. PubMed ID: 4313727
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of serum cortisol measurement by immunoassay and liquid chromatography-tandem mass spectrometry in patients receiving the 11β-hydroxylase inhibitor metyrapone.
    Monaghan PJ; Owen LJ; Trainer PJ; Brabant G; Keevil BG; Darby D
    Ann Clin Biochem; 2011 Sep; 48(Pt 5):441-6. PubMed ID: 21813575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An acute rise in serum phosphorus after single-dose oral metyrapone.
    Akgun S; Ertel NH; Schneider G
    J Endocrinol Invest; 1979; 2(3):275-9. PubMed ID: 528778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressive effect of metyrapone on plasma corticotrophin immunoreactivity in normal man.
    Schöneshöfer M; Fenner A; Claus M
    Clin Endocrinol (Oxf); 1983 Apr; 18(4):363-70. PubMed ID: 6307549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary response to metyrapone in Gulf War veterans: relationship to deployment, PTSD and unexplained health symptoms.
    Golier JA; Schmeidler J; Yehuda R
    Psychoneuroendocrinology; 2009 Oct; 34(9):1338-45. PubMed ID: 19446401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.